cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Lianbio
1 own
Current Price
$4.07
$0.02
(0.49%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
269.75M
52-Week High
52-Week High
4.56000
52-Week Low
52-Week Low
1.21000
Average Volume
Average Volume
0.18M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization269.75M
icon52-Week High4.56000
icon52-Week Low1.21000
iconAverage Volume0.18M
iconDividend Yield--
iconP/E Ratio--
What does the Lianbio do?
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex blepharitis; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of second-line and first-line cholangiocarcinoma, and gastric cancers; BBP-398 for solid tumors; Omilancor for ulcerative colitis and Crohn s disease; NX-13 for ulcerative colitis; LYR-210 for chronic rhinosinusitis; and Sisunatovir for respiratory syncytical virus. It has a partnership with Tarsus Pharmaceuticals, Inc. to develop and commercialize TP-03, an eye solution for the treatment of Demodex blepharitis; and Nanobiotix S.A. to develop and commercialize NBTXR3, a radioenhancer designed to be injected directly into a malignant tumor prior to standard radiotherapy. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey.
Read More
How much money does Lianbio make?
News & Events about Lianbio.
Globe Newswire
5 months ago
SHANGHAI, China and PRINCETON, N.J., June 26, 2023 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other Asian markets,today announced that CAMZYOS (mavacamten) has received marketing approval for the treatment ...
Globe Newswire
7 months ago
SHANGHAI, China and PRINCETON, N.J., April 21, 2023 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced the promotion of Pascal Qian to the position of Chief Commercial ...
Globe Newswire
7 months ago
SHANGHAI, China and PRINCETON, N.J., April 21, 2023 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that Chinas National Medical Products Administration (NMPA) has ...
Globe Newswire
8 months ago
Phase 3 trial of mavacamten in Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) ongoing, with data expected mid-year 2023 Phase 3 registrational trial of TP-03 in Chinese patients with Demodex blepharitis ongoing, with data expected in the fourth quarter of 2023 ...
Globe Newswire
1 year ago
SHANGHAI, China and PRINCETON, N.J., Nov. 10, 2022 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that members of the management team will participate in the following ...
Frequently Asked Questions
Frequently Asked Questions
What is Lianbio share price today?
plus_minus_icon
Can Indians buy Lianbio shares?
plus_minus_icon
How can I buy Lianbio shares from India?
plus_minus_icon
Can Fractional shares of Lianbio be purchased?
plus_minus_icon
What are the documents required to start investing in Lianbio stocks?
plus_minus_icon
What is today’s traded volume of Lianbio?
plus_minus_icon
What is today’s market capitalisation of Lianbio?
plus_minus_icon
What is the 52-Week High and Low Range of Lianbio?
plus_minus_icon
What percentage is Lianbio down from its 52-Week High?
plus_minus_icon
What percentage is Lianbio up from its 52-Week Low?
plus_minus_icon
Current Price
$4.07
$0.02
(0.49%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00